bioRxivBioengineering
A Self-Purifying Microfluidic System for Identifying Drugs Acting Against Adult Schistosomes
V. Girod, M.-J. Ghoris, S. Caby, C. Dissous, O. Melnyk, V. Senez, J. Vicogne
Abstract
The discovery of novel antihelminthic molecules to combat the development and spread of schistosomiasis, a disease caused by several Schistosoma flatworm species, mobilizes significant research efforts worldwide. In the absence of reliable and practical biochemical assays for measuring the viability of adult worms, the antischistosomicidal activity of molecules is usually evaluated by a detailed microscopic observation of worm mobility and/or integrity upon drug exposure. These assays have the disadvantage of being inacurate, subjective, biased by the limited in vitro worm viability and difficult to integrate at high density. We describe here a self-purifiying microfluidic system enabling the selection of healthy adult worms and the identification of molecules acting on the parasite. The worms are assayed in a dynamic environment that eliminates unhealthy worms that cannot attach firmly to the chip walls prior to being exposed to the drug. The detachment of the worms is also used as second step readout for identifying active compounds. We have validated this new fluidic screening approach using the two major antihelmintic drugs, Praziquantel and Artemisinin. The reported dynamic system is simple to produce and to parallelize. Importantly, it enables a quick, sensitive and reliable detection of antischistosomal compounds in no more than one day. This system can potentially be modified in the future to better mimic the natural habitat of the parasite.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing
S. Frahm, A. Anisuzzaman, … C. Prazeres da Costa·bioRxiv·Jun 7, 2018
- Small change, big difference: A novel praziquantel derivative P96 with multistage antischistosomal activity for chemotherapy of schistosomiasis japonica
J. Xu, L.-L. Dong, … C.-M. Xia·bioRxiv·Mar 6, 2023
- A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
S. Chen, B. M. Suzuki, … C. R. Caffrey·bioRxiv·Oct 6, 2020
- Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms
K. T. Ryan, N. J. Wheeler, … J. D. Chan·bioRxiv·Sep 12, 2022
- A rotifer-derived paralytic compound prevents transmission of schistosomiasis to a mammalian host
J. Gao, N. Yang, … P. A. Newmark·bioRxiv·Jun 1, 2019
- Direct measurement of in vitro response to Praziquantel in Schistosoma mansoni populations from Western Kenya
Eric M. Ndombi, John K. Oguso, … Timothy J. C. Anderson·bioRxiv·Jul 22, 2026